PETMED EXPRESS INC (PETS) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — PETS

Balance Sheet

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	26.91	36.10	41.13	50.10	52.05	45.99	49.44	53.47	61.53	102.43	96.55	105.41	106.56	111.79	108.91	106.34	86.82
Accounts Receivable	1.56	1.97	1.61	2.26	1.62	2.26	1.93	2.17	1.89	1.94	1.59	1.78	1.85	2.16	1.27	2.21	2.71
Inventory	12.21	14.77	18.36	11.80	13.09	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Assets	48.51	59.46	67.89	68.38	70.78	77.62	95.55	84.64	104.81	134.02	138.22	134.19	133.45	147.18	142.90	132.62	135.88
Property, Plant & Equipment	27.55	28.34	28.84	28.43	26.20	26.11	26.81	26.97	27.21	25.24	25.19	24.69	25.08	25.28	24.67	25.47	26.02
Goodwill	0.00	0.00	0.00	26.66	26.66	26.66	26.66	26.66	26.66	--	--	--	--	--	--	--	--
Intangible Assets	5.98	6.47	6.96	9.74	10.22	10.71	11.69	12.18	12.67	--	--	0.86	0.86	0.86	0.86	0.86	0.86
Total Non-current Assets	39.46	40.85	41.95	76.41	75.26	75.09	77.80	78.06	79.47	31.10	31.05	30.55	25.94	26.14	25.53	26.33	26.88
Total Assets	87.97	100.30	109.84	144.79	146.03	152.71	173.35	162.70	184.28	165.12	169.27	164.74	159.39	173.32	168.43	158.95	162.76
Accounts Payable	20.30	19.12	20.04	10.95	16.95	24.47	38.85	25.38	40.04	24.32	23.98	17.03	11.18	24.71	21.94	16.06	20.98
Total Current Liabilities	54.77	56.68	57.62	47.96	48.83	58.30	72.40	61.24	78.76	31.07	30.57	23.90	16.27	31.86	26.27	21.16	29.17
Total Non-current Liabilities*	0.43	0.55	0.68	0.65	0.77	0.88	0.89	1.08	1.27	0.47	0.55	0.64	1.63	1.11	1.26	1.38	0.72
Total Liabilities	55.20	57.24	58.29	48.61	49.60	59.18	73.29	62.32	80.03	31.54	31.11	24.54	17.90	32.98	27.53	22.54	29.88
Retained Earnings	13.32	23.87	32.39	78.19	78.89	76.56	76.56	78.58	84.18	116.91	123.25	126.97	132.75	132.49	130.72	131.06	128.30
Total Stockholder Equity	32.77	43.06	51.55	96.18	96.43	93.53	100.06	100.38	104.24	133.59	138.15	140.20	141.49	140.35	140.90	136.41	132.87

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q2 2022	Q1 2022	Q4 2021
Total Revenue	42.82	40.66	44.36	51.18	46.47	52.98	59.57	67.95	66.50	65.32	71.00	78.24	62.13	58.87	65.39	70.19	66.00	67.39	79.31	71.68
Cost of Revenue*	28.88	31.20	31.95	36.78	27.52	38.08	42.26	49.98	48.33	47.43	50.94	55.72	45.03	43.63	46.94	50.24	46.61	48.21	57.53	51.16
Gross Profit	13.94	9.46	12.42	14.40	18.95	14.91	17.31	17.97	18.18	17.88	20.06	22.53	17.10	15.24	18.45	19.94	19.40	19.17	21.78	20.52
Selling, General & Admin	11.42	12.19	14.18	12.95	12.49	10.79	10.49	4.87	14.15	13.43	11.96	15.71	11.19	10.43	10.75	9.35	8.29	6.96	8.04	7.24
Total Operating Expenses	19.63	19.93	20.80	48.54	24.97	15.36	16.76	13.59	22.01	20.96	19.19	24.65	16.73	16.01	15.49	16.45	12.34	11.09	16.36	12.14
Operating Income	(5.69)	(10.47)	(8.38)	(34.13)	(6.02)	(0.45)	0.55	4.39	(3.83)	(3.07)	0.88	(2.13)	0.37	(0.77)	2.96	3.49	7.06	8.09	5.42	8.39
Pretax Income	(4.16)	(10.54)	(8.51)	(34.14)	(5.98)	(0.24)	0.93	4.71	(3.48)	(2.64)	1.28	(1.43)	(0.17)	0.20	3.61	3.81	7.43	8.33	5.79	8.85
Tax Provision	(0.10)	0.01	0.01	0.01	5.66	0.47	(1.40)	0.96	1.54	(0.62)	0.56	(0.29)	0.03	0.22	1.03	1.03	1.37	1.98	1.36	2.04
Net Income	(4.06)	(10.55)	(8.52)	(34.15)	(11.64)	(0.71)	2.33	3.75	(5.02)	(2.03)	0.72	(1.14)	(0.19)	(0.02)	2.58	2.78	6.07	6.35	4.43	6.81
Basic EPS	(0.18)	(0.50)	(0.41)	(1.65)	(0.56)	(0.03)	0.11	0.18	(0.23)	(0.10)	0.04	(0.06)	(0.26)	0.00	0.13	0.14	0.31	0.31	0.22	0.34
Diluted EPS	(0.18)	(0.50)	(0.41)	(1.65)	(0.56)	(0.03)	0.11	0.18	(0.23)	(0.10)	0.03	(0.06)	(0.26)	0.00	0.13	0.14	0.30	0.31	0.22	0.33

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	(4.74)	(9.20)	(2.17)	(12.27)	7.01	(1.17)	7.39	(8.52)	7.13	(2.59)	(0.78)	0.56	9.72	12.97	(1.27)	6.38	1.50	(0.42)	18.45	9.78
Capital Expenditures	0.72	(0.02)	2.62	1.29	2.39	0.78	1.26	0.68	1.25	1.12	0.98	1.15	1.93	0.99	1.35	0.98	0.50	0.48	0.58	1.27
Free Cash Flow*	(5.46)	(9.18)	(4.80)	(13.56)	4.62	(1.94)	6.12	(9.20)	5.87	(3.72)	(1.76)	(0.59)	7.79	11.98	(2.63)	5.40	1.00	(0.90)	17.86	8.52
Investing Cash Flow	(0.72)	0.02	(2.62)	(1.29)	(2.39)	(0.78)	(1.26)	(0.68)	(1.25)	(1.42)	(0.98)	(37.01)	(1.93)	(0.99)	(1.35)	(5.98)	(0.49)	(0.48)	(0.58)	(1.27)
Financing Cash Flow	(0.04)	0.00	(0.23)	(0.03)	-0.00	-0.00	(0.07)	(0.10)	(0.02)	(0.01)	(6.30)	(6.10)	(6.13)	(6.10)	(6.24)	(6.06)	(6.23)	(6.03)	(5.65)	(6.91)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Dividends Per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.28	0.30	0.28	0.28	0.27